UPDATED 20.02.2014 10:55

Organised cervical cancer screening programme in the Helsinki and Uusimaa health care district in Finland in the invitation year 2005. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 20013 347 1.73 2 0.01 - - 3 0.01 6 0.03 60 0.30 37 0.18 239 1.19
I 18100 1 - - - - - - - - - - - - - 1 -
II 1531 36 0.18 1 - - - - - - - - - 2 0.01 33 0.16
III 302 302 1.51 1 - - - 3 0.01 4 0.02 58 0.29 35 0.17 201 1.00
IV 8 8 0.04 - - - - - - 2 0.01 2 0.01 - - 4 0.02
V - - - - - - - - - - - - - - - - -
Inadequate 72 - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test 8659 146 1.69 - - - - - - 7 0.08 38 0.44 18 0.21 83 0.96
Negative1 7707 4 0.05 - - - - - - - - - - - - 4 0.05
Positive2 952 142 1.64 - - - - - - 7 0.08 38 0.44 18 0.21 79 0.91
Total 28672 493 1.72 2 0.01 - - 3 0.01 13 0.05 98 0.34 55 0.19 322 1.12

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.